John E. Nichols — Endo Lab

other 2025

Machine learning center-specific models show improved IVF live birth predictions over US national registry-based model

Nature communications ·doi:10.1038/s41467-025-58744-z

Expanding in vitro fertilization (IVF) access requires improved patient counseling and affordability via cost-success transparency. Clinicians ask how two types of live birth prediction (LBP) models perform: machine learning, center-specifi…

other 2021

Real-world experience with intravaginal culture using INVOCELL: an alternative model for infertility treatment

F&S reports ·doi:10.1016/j.xfre.2020.11.003

OBJECTIVE: To describe the current practice indications, methodology, and outcomes from a real-world experience of intravaginal culture (IVC) using INVOCELL. DESIGN: A descriptive study outlining real-world experience with INVOCELL that ad…

rct 2003

Highly purified human-derived follicle-stimulating hormone (Bravelle) has equivalent efficacy to follitropin-beta (Follistim) in infertile women undergoing in vitro fertilization

Reproductive biology and endocrinology : RB&E ·doi:10.1186/1477-7827-1-63

BACKGROUND: These data compare the efficacy and safety of highly purified human-derived follicle-stimulating hormone (Bravelle) and recombinant follitropin-beta (Follistim) in women undergoing in vitro fertilization. METHODS: This report d…

rct 2001

Subcutaneously administered Repronex in oligoovulatory female patients undergoing ovulation induction is as effective and well tolerated as intramuscular human menopausal gonadotropin treatment

Fertility and sterility ·doi:10.1016/s0015-0282(01)01856-8

OBJECTIVE: To determine the efficacy and safety of Repronex SC as compared with Repronex IM and Pergonal IM in patients undergoing ovulation induction. DESIGN: Randomized, open-label, multicenter, parallel group study. SETTING: Ten academ…